Contact Us
Contact Us

OCUWELL secures additional £125k investment from LYVA Labs as part of £700k seed round

 

OCUWELL, an innovative medical technology company focused on advancing ocular health solutions, has announced the successful completion of a second £125,000 investment tranche from LYVA Labs through its Liverpool City Region Combined Authority-backed challenge fund. This latest funding brings LYVA Labs’ total investment in OCUWELL to £250,000 and forms part of the company’s £700,000 seed funding round.

The continued support from LYVA Labs reflects strong confidence in OCUWELL's vision, progress, and potential to deliver impactful solutions within the medical and engineering space. The investment will enable OCUWELL to further accelerate product development, strengthen its research and development capabilities, and advance key milestones as the company moves towards commercialisation. 

 

Rania Maklad, CEO, commented:
“We are delighted to receive continued backing from LYVA Labs. This second tranche of investment is a strong endorsement of our progress to date and our long-term vision. As part of our wider seed round, it allows us to build on our momentum and take significant steps forward in delivering innovative solutions in ocular health.”
Vijay Curthan, Investment Director, added:
“We are pleased to continue supporting OCUWELL as they progress their technology and commercial strategy. The team has demonstrated strong execution and clear potential, and we look forward to seeing their continued growth and impact. This milestone marks an important step in OCUWELL's journey as it continues to develop cutting-edge solutions and expand its presence within the healthcare innovation ecosystem".

About OCUWELL

OCUWELL is a medical technology company focused on developing innovative solutions to improve ocular health and patient outcomes through engineering-led approaches.

ocuwell thumbnail

 

About Us

Programmes

Services

Keep up to date with LYVA Labs by subscribing to our newsletter.

© 2026 LCR Ventures trading as LYVA Labs. All rights reserved.